Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Shareholders May Be More Conservative With Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) CEO Compensation For Now
Key Insights Mirum Pharmaceuticals' Annual General Meeting to take place on 5th of June Total pay for CEO Chris Peetz...
- Business Wire
Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC to be Presented at EASL Congress
FOSTER CITY, Calif., May 29, 2024--Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC to be Presented at EASL Congress
- Zacks
Mirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns
Mirum's (MIRM) lead drug, Livmarli, continues to generate steady sales. The recent label expansion of the drug should drive sales further. However, overdependence on Livmarli for revenues is a concern.
© 2024 Yahoo. All rights reserved.